Search

everythinglearnresearchcommunity

for

Search:↓

Higher levels of certain proteins in hair loss areas may help understand and treat hair loss.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Platelet-rich plasma treatment could potentially be an effective way to treat chronic alopecia areata with minimal side effects.

A protein called PCBP2 controls the production of a hair growth protein by interacting with its genetic message and is linked to hair loss when this control is disrupted.

Treatment improved scalp conditions and hair loss with no recurrence after 1 year.

DNA analysis can help tailor alopecia treatment.

A peptide from hair follicle stem cells can boost hair growth.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

Inflammation damages sweat ducts, causing sweat gland injury.

Mixing platelet-rich plasma with triamcinolone acetonide can potentially improve hair regrowth in alopecia areata patients.

PRP is an effective and safe treatment for hair loss.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

New genetic discoveries in alopecia areata could lead to better treatments.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Alopecia areata patients don't have increased atherosclerosis risk, but may have higher cardiovascular risk due to smoking, blood sugar, and blood pressure.

Higher levels of heat shock protein 27 and lower levels of miR-1 can increase AR levels, leading to hair loss in men.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

A mutation in the Soat1 gene causes hair structure defects and other health issues in AKR/J mice.

HAPLN1 can promote hair growth and may help treat hair loss.

IL16 gene variations may affect the risk of alopecia areata in Koreans.

Stress can cause a type of hair loss in mice lacking the CCHCR1 gene.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

A young woman with a rare hair loss condition improved with steroid and biotin treatment.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

DPCP immunotherapy is effective for alopecia areata, and understanding influencing factors can improve treatment and satisfaction.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Genetic marker rs12558842 strongly linked to male hair loss.

ABO/Rh blood groups are not a risk factor for PCOS.